Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data

[1] Hammond SP(2011)Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009 Antimicrob Agents Chemother 55 5018-5021

[2] Baden LR(2009)Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry Clin Infect Dis 48 265-273

[3] Marty FM(2011)Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006 Emerg Infect Dis 17 1855-1864

[4] Neofytos D(2012)Healthcare-associated mucormycosis Clin Infect Dis 54 S44-S54

[5] Horn D(2005)Epidemiology and outcome of zygomycosis: a review of 929 reported cases Clin Infect Dis 41 634-653

[6] Anaissie E(2010)Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database Clin Infect Dis 50 1091-1100

[7] Steinbach W(2010)Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis 50 1101-1111

[8] Olyaei A(2011)Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 Clin Microbiol Infect 17 1859-1867

[9] Fishman J(2010)Forty-one recent cases of invasive zygomycosis from a global clinical registry J Antimicrob Chemother 65 296-302

[10] Pfaller M(2014)Epidemiology of mucormycosis in Europe Clin Microbiol Infect 20 67-73

[1] Hammond SP(2011)Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009 Antimicrob Agents Chemother 55 5018-5021

[2] Baden LR(2009)Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry Clin Infect Dis 48 265-273

[3] Marty FM(2011)Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006 Emerg Infect Dis 17 1855-1864

[4] Neofytos D(2012)Healthcare-associated mucormycosis Clin Infect Dis 54 S44-S54

[5] Horn D(2005)Epidemiology and outcome of zygomycosis: a review of 929 reported cases Clin Infect Dis 41 634-653

[6] Anaissie E(2010)Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database Clin Infect Dis 50 1091-1100

[7] Steinbach W(2010)Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis 50 1101-1111

[8] Olyaei A(2011)Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 Clin Microbiol Infect 17 1859-1867

[9] Fishman J(2010)Forty-one recent cases of invasive zygomycosis from a global clinical registry J Antimicrob Chemother 65 296-302

[10] Pfaller M(2014)Epidemiology of mucormycosis in Europe Clin Microbiol Infect 20 67-73